Hiroaki Sakurai[Author] - Search Results

Year	Number of Results
2001	1
2002	3
2003	7
2004	4
2005	11
2006	15
2007	16
2008	8
2009	19
2010	10
2011	11
2012	17
2013	14
2014	11
2015	14
2016	9
2017	12
2018	9
2019	8
2020	9
2021	10
2022	13
2023	9
2024	6

1

Cellular stress induces non-canonical activation of the receptor tyrosine kinase EphA2 through the p38-MK2-RSK signaling pathway.

Zhou Y, Oki R, Tanaka A, Song L, Takashima A, Hamada N, Yokoyama S, Yano S, Sakurai H. Zhou Y, et al. Among authors: sakurai h. J Biol Chem. 2023 May;299(5):104699. doi: 10.1016/j.jbc.2023.104699. Epub 2023 Apr 12. J Biol Chem. 2023. PMID: 37059179 Free PMC article.

2

RSK-Mediated Non-canonical Activation of EphA2 by Tamoxifen.

Yonehara K, Zhou Y, Takahashi JI, Yokoyama S, Tomihara K, Noguchi M, Sakurai H. Yonehara K, et al. Among authors: sakurai h. Biol Pharm Bull. 2022;45(2):162-168. doi: 10.1248/bpb.b21-00567. Biol Pharm Bull. 2022. PMID: 35110502 Free article.

3

Targeting of TAK1 in inflammatory disorders and cancer.

Sakurai H. Sakurai H. Trends Pharmacol Sci. 2012 Oct;33(10):522-30. doi: 10.1016/j.tips.2012.06.007. Epub 2012 Jul 12. Trends Pharmacol Sci. 2012. PMID: 22795313 Review.

4

New trend in ligand-induced EGFR trafficking: A dual-mode clathrin-mediated endocytosis model.

Zhou Y, Sakurai H. Zhou Y, et al. Among authors: sakurai h. J Proteomics. 2022 Mar 20;255:104503. doi: 10.1016/j.jprot.2022.104503. Epub 2022 Jan 29. J Proteomics. 2022. PMID: 35093568 Review.

5

[Non-canonical Activation of Receptor Tyrosine Kinases in Cancer Progression].

Sakurai H. Sakurai H. Yakugaku Zasshi. 2017;137(2):141-144. doi: 10.1248/yakushi.16-00229-4. Yakugaku Zasshi. 2017. PMID: 28154322 Free article. Review. Japanese.

6

Emerging and Diverse Functions of the EphA2 Noncanonical Pathway in Cancer Progression.

Zhou Y, Sakurai H. Zhou Y, et al. Among authors: sakurai h. Biol Pharm Bull. 2017;40(10):1616-1624. doi: 10.1248/bpb.b17-00446. Biol Pharm Bull. 2017. PMID: 28966234 Free article. Review.

7

Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer.

Koizumi K, Kato S, Sakurai H, Hashimoto I, Yasumoto K, Saiki I. Koizumi K, et al. Among authors: sakurai h. Front Biosci (Schol Ed). 2012 Jan 1;4(1):269-76. doi: 10.2741/s267. Front Biosci (Schol Ed). 2012. PMID: 22202059 Review.

8

New Directions for Advanced Targeting Strategies of EGFR Signaling in Cancer.

Zhou Y, Takahashi JI, Sakurai H. Zhou Y, et al. Among authors: sakurai h. Biol Pharm Bull. 2024;47(5):895-903. doi: 10.1248/bpb.b23-00924. Biol Pharm Bull. 2024. PMID: 38692865 Free article. Review.

9

Wearable robotic exoskeleton for gait reconstruction in patients with spinal cord injury: A literature review.

Tan K, Koyama S, Sakurai H, Teranishi T, Kanada Y, Tanabe S. Tan K, et al. Among authors: sakurai h. J Orthop Translat. 2021 Mar 1;28:55-64. doi: 10.1016/j.jot.2021.01.001. eCollection 2021 May. J Orthop Translat. 2021. PMID: 33717982 Free PMC article. Review.

10

Non-canonical Regulation of EGFR by the Air Pollutant 9,10-Phenanthrenequinone.

Yamagishi N, Takahashi JI, Zhou Y, Yokoyama S, Makino T, Shimizu T, Sakurai H. Yamagishi N, et al. Among authors: sakurai h. Biol Pharm Bull. 2022;45(10):1553-1558. doi: 10.1248/bpb.b22-00489. Biol Pharm Bull. 2022. PMID: 36184515 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

216 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Results by year